use AI to build a company selling GLP1 drugs

Here's a one-paragraph summary with the AMA citation: This episode examines Medvi, a telehealth startup founded by Matthew Gallagher that is projected to generate $1.8 billion in revenue in 2026 with just two employees — Gallagher and his brother Elliot — operating out of a house in Los Angeles. Drawing on Erin Griffith's front-page New York Times investigation, the episode traces Gallagher's path from a transient childhood in Cincinnati to building a hyper-efficient AI-powered business by layering automated customer intake and marketing tools on top of existing telehealth infrastructure provided by CareValidate and OpenLoop Health. The discussion covers the mechanics of how the model works, the risks of running a billion-dollar operation as essentially a one-man system (including a now-infamous hike that cost him 200 customers when a routine code update broke checkout), the AI hallucinations that led to costly pricing errors, and the surprising human conclusion: that after optimizing away nearly all friction and overhead to achieve a 16.2% net profit margin — nearly triple that of publicly traded competitor Hims & Hers — Gallagher admits he misses his colleagues and is, in his own words, lonely. Source: Griffith E. How A.I. helped one man (and his brother) build a $1.8 billion company. The New York Times. April 2, 2026; Section A:1. https://www.nytimes.com/2026/04/02/technology/ai-billion-dollar-company-medvi.html